Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

642
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
642
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

597
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
597
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

833
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
833
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

880
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
880
Vaccines01:21

Vaccines

62
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
62

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of the inflammasome-dependent cytokine IL-18 with risk of coronary heart disease.

Cardiovascular research·2026
Same author

LL-37 IgG levels are associated with clinical characteristics and T follicular cell response in acute coronary syndrome in adults.

Physiological reports·2026
Same author

Development and validation of two brief versions of the Nurse Professional Competence (NPC) Scale: The NPC-6 and NPC-12.

Nurse education today·2026
Same author

Adaptive immune response to the autoantigen LL-37 differentiates atherosclerotic cardiovascular disease phenotypes.

Clinical & translational immunology·2026
Same author

Deletion of PKM2 in Macrophages Promotes Stabilization but Not Regression of Atherosclerotic Plaques.

Circulation research·2026
Same author

Associations between the C-reactive protein-triglyceride glucose index and the incidence and progression trajectory of cardiometabolic multimorbidity: a multi-state model study.

Cardiovascular diabetology·2026

Related Experiment Video

Updated: Apr 19, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.2K

Vaccine for atherosclerosis.

Prediman K Shah1, Kuang-Yuh Chyu1, Paul C Dimayuga1

  • 1Oppenheimer Atherosclerosis Research Center, Division of Cardiology, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California.

Journal of the American College of Cardiology
|December 27, 2014
PubMed
Summary
This summary is machine-generated.

Active immunization strategies targeting immune responses in atherosclerosis show promise for altering disease progression. This review explores immune system roles, vaccine antigens, and future clinical applications for atherosclerosis prevention.

Keywords:
T-lymphocytesapolipoprotein B-100atherosclerotic plaquecardiovascular diseasesdendritic cellslow-density lipoproteins

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

41.2K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

9.0K
Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

7.8K

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Pathology

Background:

  • Atherosclerosis is an immune-mediated inflammatory disease affecting arterial walls.
  • Both innate and adaptive immune systems play complex roles, with both proatherogenic and atheroprotective functions.
  • Understanding these immune interactions is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To review the multifaceted roles of the immune system in atherogenesis.
  • To examine antigens successfully used in pre-clinical atherosclerosis vaccine models.
  • To discuss the potential and challenges of clinical atherosclerosis vaccination.

Main Methods:

  • Literature review of immunological and cardiovascular research.
  • Analysis of pre-clinical vaccine studies for atherosclerosis.
  • Discussion of clinical translation opportunities and hurdles.

Main Results:

  • The immune system's involvement in atherosclerosis is complex, with diverse roles.
  • Several antigens have demonstrated efficacy in reducing atherosclerosis in experimental models.
  • Vaccine strategies show potential but face significant challenges for clinical application.

Conclusions:

  • Immunomodulatory strategies, particularly active immunization, hold promise for altering atherosclerosis progression.
  • Further research is needed to overcome challenges in translating pre-clinical findings to human therapies.
  • Targeting specific immune components offers a potential avenue for future atherosclerosis treatment and prevention.